SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

Citigroup Initiates Coverage On Alnylam Pharmaceuticals with Buy Rating, Announces Price Target of $170

Citigroup analyst Joel Beatty initiates coverage on Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy rating and announces Price Target of $170.

· 09/08/2020 06:49
Citigroup analyst Joel Beatty initiates coverage on Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy rating and announces Price Target of $170.